Literature DB >> 30382507

Phosphorylated TDP-43 Staging of Primary Age-Related Tauopathy.

Xiaoling Zhang1, Bing Sun1, Xing Wang2, Hui Lu1, Fangjie Shao2, Annemieke J M Rozemuller3, Huazheng Liang4, Chong Liu1,2, Jiadong Chen1, Manli Huang5, Keqing Zhu6,7.   

Abstract

Primary age-related tauopathy (PART) is characterized by tau neurofibrillary tangles (NFTs) in the absence of amyloid plaque pathology. In the present study, we analyzed the distribution patterns of phosphorylated 43-kDa TAR DNA-binding protein (pTDP-43) in the brains of patients with PART. Immunohistochemistry and immunofluorescence double-labeling in multiple brain regions was performed on brain tissues from PART, Alzheimer's disease (AD), and aging control cases. We examined the regional distribution patterns of pTDP-43 intraneuronal inclusions in PART with Braak NFT stages > 0 and ≤ IV, and a Thal phase of 0 (no beta-amyloid present). We found four stages which indicated potentially sequential dissemination of pTDP-43 in PART. Stage I was characterized by the presence of pTDP-43 lesions in the amygdala, stage II by such lesions in the hippocampus, stage III by spread of pTDP-43 to the neocortex, and stage IV by pTDP-43 lesions in the putamen, pallidum, and insular cortex. In general, the distribution pattern of pTDP-43 pathology in PART cases was similar to the early TDP-43 stages reported in AD, but tended to be more restricted to the limbic system. However, there were some differences in the distribution patterns of pTDP-43 between PART and AD, especially in the dentate gyrus of the hippocampus. Positive correlations were found in PART between the Braak NFT stage and the pTDP-43 stage and density.

Entities:  

Keywords:  Alzheimer’s disease; Hippocampus; Neurofibrillary tangle; Primary age-related tauopathy; TDP-43

Mesh:

Substances:

Year:  2018        PMID: 30382507      PMCID: PMC6426920          DOI: 10.1007/s12264-018-0300-0

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  27 in total

1.  Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease.

Authors:  William T Hu; Keith A Josephs; David S Knopman; Bradley F Boeve; Dennis W Dickson; Ronald C Petersen; Joseph E Parisi
Journal:  Acta Neuropathol       Date:  2008-07-01       Impact factor: 17.088

2.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

3.  Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness.

Authors:  Felix Geser; John L Robinson; Joseph A Malunda; Sharon X Xie; Chris M Clark; Linda K Kwong; Paul J Moberg; Erika M Moore; Vivianna M Van Deerlin; Virginia M-Y Lee; Steven E Arnold; John Q Trojanowski
Journal:  Arch Neurol       Date:  2010-10

Review 4.  TDP-43: a DNA and RNA binding protein with roles in neurodegenerative diseases.

Authors:  Sadaf T Warraich; Shu Yang; Garth A Nicholson; Ian P Blair
Journal:  Int J Biochem Cell Biol       Date:  2010-06-25       Impact factor: 5.085

Review 5.  TDP-43 in aging and Alzheimer's disease - a review.

Authors:  Andrea C Wilson; Brittany N Dugger; Dennis W Dickson; Deng-Shun Wang
Journal:  Int J Clin Exp Pathol       Date:  2011-01-30

6.  TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies.

Authors:  Stacy J Arnold; Brittany N Dugger; Thomas G Beach
Journal:  Acta Neuropathol       Date:  2013-04-20       Impact factor: 17.088

7.  Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.

Authors:  Tetsuaki Arai; Ian R A Mackenzie; Masato Hasegawa; Takashi Nonoka; Kazhuhiro Niizato; Kuniaki Tsuchiya; Shuji Iritani; Mitsumoto Onaya; Haruhiko Akiyama
Journal:  Acta Neuropathol       Date:  2009-01-13       Impact factor: 17.088

8.  TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

Authors:  Catalina Amador-Ortiz; Wen-Lang Lin; Zeshan Ahmed; David Personett; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Michael L Hutton; Dennis W Dickson
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

9.  Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Masato Hasegawa; Tetsuaki Arai; Takashi Nonaka; Fuyuki Kametani; Mari Yoshida; Yoshio Hashizume; Thomas G Beach; Emanuele Buratti; Francisco Baralle; Mitsuya Morita; Imaharu Nakano; Tatsuro Oda; Kuniaki Tsuchiya; Haruhiko Akiyama
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

10.  TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype.

Authors:  Yvonne S Davidson; Samantha Raby; Penelope G Foulds; Andrew Robinson; Jennifer C Thompson; Stephen Sikkink; Imran Yusuf; Hanan Amin; Daniel DuPlessis; Claire Troakes; Safa Al-Sarraj; Carolyn Sloan; Margaret M Esiri; Vee P Prasher; David Allsop; David Neary; Stuart M Pickering-Brown; Julie S Snowden; David M A Mann
Journal:  Acta Neuropathol       Date:  2011-10-04       Impact factor: 17.088

View more
  15 in total

Review 1.  Primary Age-Related Tauopathy (PART): Addressing the Spectrum of Neuronal Tauopathic Changes in the Aging Brain.

Authors:  Richard A Hickman; Xena E Flowers; Thomas Wisniewski
Journal:  Curr Neurol Neurosci Rep       Date:  2020-07-14       Impact factor: 5.081

2.  Primary age-related tauopathy in a Chinese cohort.

Authors:  Xin Wang; Lei Zhang; Hui Lu; Juan-Li Wu; Hua-Zheng Liang; Chong Liu; Qing-Qing Tao; Zhi-Ying Wu; Ke-Qing Zhu
Journal:  J Zhejiang Univ Sci B       Date:  2020 Mar.       Impact factor: 3.066

3.  Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration.

Authors:  Alexandre Bejanin; Melissa E Murray; Peter Martin; Hugo Botha; Nirubol Tosakulwong; Christopher G Schwarz; Matthew L Senjem; Gael Chételat; Kejal Kantarci; Clifford R Jack; Bradley F Boeve; David S Knopman; Ronald C Petersen; Caterina Giannini; Joseph E Parisi; Dennis W Dickson; Jennifer L Whitwell; Keith A Josephs
Journal:  Brain       Date:  2019-11-01       Impact factor: 13.501

Review 4.  Recent update on the heterogeneity of the Alzheimer's disease spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-12-17       Impact factor: 3.575

5.  Treadmill Exercise Relieves Chronic Restraint Stress-induced Cognitive Impairments in Mice Via Activating Protein Phosphatase 2A.

Authors:  Wenjing Zhang; Haining Ou; Borui Zhang; Meifeng Zheng; Lan Yan; Yang Chen; Kwok-Fai So; Li Zhang
Journal:  Neurosci Bull       Date:  2021-08-26       Impact factor: 5.271

6.  Progressive medial temporal degeneration with TDP-43 pathology is associated with upper limb and bulbar onset types of amyotrophic lateral sclerosis.

Authors:  Takahiro Takeda; Sayuri Kokubun; Yumiko Saito; Atsuko Tsuneyama; Ai Ishikawa; Sagiri Isose; Kimiko Ito; Kimihito Arai; Akihiro Koreki; Atsuhiko Sugiyama; Satoshi Kuwabara; Kazuhiro Honda
Journal:  J Neurol       Date:  2022-06-16       Impact factor: 6.682

7.  Brain atrophy in primary age-related tauopathy is linked to transactive response DNA-binding protein of 43 kDa.

Authors:  Keith A Josephs; Melissa E Murray; Nirubol Tosakulwong; Stephen D Weigand; David S Knopman; Ronald C Petersen; Clifford R Jack; Jennifer L Whitwell; Dennis W Dickson
Journal:  Alzheimers Dement       Date:  2019-05-02       Impact factor: 21.566

8.  Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease.

Authors:  Robin de Flores; Laura E M Wisse; Sandhitsu R Das; Long Xie; Corey T McMillan; John Q Trojanowski; John L Robinson; Murray Grossman; Edward Lee; David J Irwin; Paul A Yushkevich; David A Wolk
Journal:  Alzheimers Dement       Date:  2020-04-22       Impact factor: 21.566

9.  Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.

Authors:  Peter T Nelson; Dennis W Dickson; John Q Trojanowski; Clifford R Jack; Patricia A Boyle; Konstantinos Arfanakis; Rosa Rademakers; Irina Alafuzoff; Johannes Attems; Carol Brayne; Ian T S Coyle-Gilchrist; Helena C Chui; David W Fardo; Margaret E Flanagan; Glenda Halliday; Suvi R K Hokkanen; Sally Hunter; Gregory A Jicha; Yuriko Katsumata; Claudia H Kawas; C Dirk Keene; Gabor G Kovacs; Walter A Kukull; Allan I Levey; Nazanin Makkinejad; Thomas J Montine; Shigeo Murayama; Melissa E Murray; Sukriti Nag; Robert A Rissman; William W Seeley; Reisa A Sperling; Charles L White; Lei Yu; Julie A Schneider
Journal:  Brain       Date:  2019-06-01       Impact factor: 15.255

10.  LATE to the PART-y.

Authors:  Keith A Josephs; Ian Mackenzie; Matthew P Frosch; Eileen H Bigio; Manuela Neumann; Tetsuaki Arai; Brittany N Dugger; Bernardino Ghetti; Murray Grossman; Masato Hasegawa; Karl Herrup; Janice Holton; Kurt Jellinger; Tammaryn Lashley; Kirsty E McAleese; Joseph E Parisi; Tamas Revesz; Yuko Saito; Jean Paul Vonsattel; Jennifer L Whitwell; Thomas Wisniewski; William Hu
Journal:  Brain       Date:  2019-09-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.